Kathleen Krüger Peres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kathleen Krüger Peres has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Isabella Rosa da Mata
UFCSPA
3 shared publications - Larissa Slongo Faccioli
Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
3 shared publications - Simone Morelo Dal Bosco
Centro Universitário Univates
3 shared publications - Anna Caroline Cristofoli Bertoletti
UFCSPA
2 shared publications - Carine Fabiana Saul
Universidade Federal de Ciências da Saúde de Porto Alegre
2 shared publications - Caroline Joana Kuyven
Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 41, e2021360
Early exposure to agricultural pesticides and the occurrence of autism spectrum disorder: a systematic review
Objective: The aim of this study was to evaluate the influence of early exposure to agricultural pesticides and their relationship with autism spectrum disorder. Data source: This systematic review was registered at PROSPERO as CRD42020204842. The subject was systematically analyzed on PubMed, Scopus, and Web of Science databases until April 2021. Only studies with humans with early exposure to agricultural pesticides and diagnosis of autism were included. Exclusion criteria were studies on pesticides for domestic or veterinary use and late exposure. There were no language and time restriction. The quality analysis of the studies used the Newcastle-Ottawa Scale. Data synthesis: Six case-control studies were included; three of them measured the route of exposure by maternal biomarkers and the others by the residence address. The studies had scores between moderate and high in the quality assessment tool. It was found high rates of association between early exposure to agricultural pesticides and autism and detection limit above the quantification for a sample of polychlorinated biphenyls, hexachlorobenzene, and dichlorodiphenyldichloroethylene. Conclusions: There is evidence concerning the exposure to agricultural pesticides in early life and the development of the autism spectrum disorder; however, more studies are required to better understand their possible association.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 41, e2021360
Open AccessEarly exposure to agricultural pesticides and the occurrence of autism spectrum disorder: a systematic review
Objective: The aim of this study was to evaluate the influence of early exposure to agricultural pesticides and their relationship with autism spectrum disorder. Data source: This systematic review was registered at PROSPERO as CRD42020204842. The subject was systematically analyzed on PubMed, Scopus, and Web of Science databases until April 2021. Only studies with humans with early exposure to agricultural pesticides and diagnosis of autism were included. Exclusion criteria were studies on pesticides for domestic or veterinary use and late exposure. There were no language and time restriction. The quality analysis of the studies used the Newcastle-Ottawa Scale. Data synthesis: Six case-control studies were included; three of them measured the route of exposure by maternal biomarkers and the others by the residence address. The studies had scores between moderate and high in the quality assessment tool. It was found high rates of association between early exposure to agricultural pesticides and autism and detection limit above the quantification for a sample of polychlorinated biphenyls, hexachlorobenzene, and dichlorodiphenyldichloroethylene. Conclusions: There is evidence concerning the exposure to agricultural pesticides in early life and the development of the autism spectrum disorder; however, more studies are required to better understand their possible association.
- Open Access
- 13 December 2022
- Published by Universidade Federal de Sao Paulo in Revista Neurociências
- Vol. 30, 1-24
Efeitos da suplementação com resveratrol no humor: uma revisão sistemática
Introdução. O resveratrol é um estilbeno encontrado em alguns alimentos. Os efeitos desse polifenol estão sendo cada vez mais estudados, devido ao seu potencial antioxidante e preventivo contra doenças neurodegenerativas. Além disso, sugere-se que a suplementação com resveratrol pode causar um efeito benéfico no humor. Objetivo. Esta revisão tem como objetivo avaliar ensaios clínicos randomizados que analisaram os efeitos do resveratrol no humor, por meio de suplementação oral. Método. Foram identificados estudos publicados até 20 de novembro de 2020 nas bases de dados PubMed, Web of Science e Scopus. Os critérios de inclusão foram: o termo resveratrol incluído no título, resumo ou palavra-chave; artigos em adultos saudáveis ou mulheres saudáveis no período pós-menopausa; tratamento apenas com suplementos orais. Esta revisão sistemática foi registrada no PROSPERO (CRD42020205072). A análise das evidências foi realizada pela ferramenta de avaliação do risco de viés (RoB 2.0). Resultados. Um total de 5 estudos envolvendo 339 participantes foram incluídos. Um estudo demonstrou resultados significantes, um na redução da fadiga, um na redução da ansiedade e dois no aumento do bem-estar geral. Nesses casos, o resveratrol demonstrou melhorar certos aspectos dos estados de humor; no entanto, a concordância entre os estudos é limitada. Conclusão. Com base nos resultados desta revisão, a literatura atual não fornece suporte suficiente para correlacionar a suplementação de resveratrol com melhora no humor, pesquisas com um tamanho amostral maior e alta qualidade metodológica são necessárias para medir a eficácia legítima do resveratrol no humor.
- 13 December 2022
- Published by Universidade Federal de Sao Paulo in Revista Neurociências
- Vol. 30, 1-24
Open AccessEfeitos da suplementação com resveratrol no humor: uma revisão sistemática
Introdução. O resveratrol é um estilbeno encontrado em alguns alimentos. Os efeitos desse polifenol estão sendo cada vez mais estudados, devido ao seu potencial antioxidante e preventivo contra doenças neurodegenerativas. Além disso, sugere-se que a suplementação com resveratrol pode causar um efeito benéfico no humor. Objetivo. Esta revisão tem como objetivo avaliar ensaios clínicos randomizados que analisaram os efeitos do resveratrol no humor, por meio de suplementação oral. Método. Foram identificados estudos publicados até 20 de novembro de 2020 nas bases de dados PubMed, Web of Science e Scopus. Os critérios de inclusão foram: o termo resveratrol incluído no título, resumo ou palavra-chave; artigos em adultos saudáveis ou mulheres saudáveis no período pós-menopausa; tratamento apenas com suplementos orais. Esta revisão sistemática foi registrada no PROSPERO (CRD42020205072). A análise das evidências foi realizada pela ferramenta de avaliação do risco de viés (RoB 2.0). Resultados. Um total de 5 estudos envolvendo 339 participantes foram incluídos. Um estudo demonstrou resultados significantes, um na redução da fadiga, um na redução da ansiedade e dois no aumento do bem-estar geral. Nesses casos, o resveratrol demonstrou melhorar certos aspectos dos estados de humor; no entanto, a concordância entre os estudos é limitada. Conclusão. Com base nos resultados desta revisão, a literatura atual não fornece suporte suficiente para correlacionar a suplementação de resveratrol com melhora no humor, pesquisas com um tamanho amostral maior e alta qualidade metodológica são necessárias para medir a eficácia legítima do resveratrol no humor.
- Open Access
- 1 May 2021
- Published by MedCrave Group Kft. in International Physical Medicine & Rehabilitation Journal
- Vol. 6 (3) , 67-68
Garcinia cambogia and diabetes mellitus: a lack of evidence?
Diabetes Mellitus is a disease characterized by hyperglycemia resulting from defects in insulin secretion. Garcinia Cambogia is an Asian plant used commonly as nutritional supplement for weight loss. Objective: The purpose of this study is to perform a mini review about Garcinia Cambogia consumption and itsrelationship with DM condition in humans. Methods: Studies were searched in Pubmed, Web of Science and Scopus databases and 62 articles wereidentified and reviewed in an integrative method. After a criterial analysis, 3 articles were included on this mini review. Results: Two studies found that Garcinia Cambogia in association with Glucomannan had a positive associationrelated to comorbidities as Diabetes Mellitus and its markers (glycemia, triglycerides, cholesterol). However, a case report showed an adverse effect on a high dose Garcinia Cambogia consumption. Conclusion: It is possible that Garcinia Cambogia consumption influences DiabetesMellituscondition, althoughmore studies are necessary for higher efficacy understanding.
- 1 May 2021
- Published by MedCrave Group Kft. in International Physical Medicine & Rehabilitation Journal
- Vol. 6 (3) , 67-68
Open AccessGarcinia cambogia and diabetes mellitus: a lack of evidence?
Diabetes Mellitus is a disease characterized by hyperglycemia resulting from defects in insulin secretion. Garcinia Cambogia is an Asian plant used commonly as nutritional supplement for weight loss. Objective: The purpose of this study is to perform a mini review about Garcinia Cambogia consumption and itsrelationship with DM condition in humans. Methods: Studies were searched in Pubmed, Web of Science and Scopus databases and 62 articles wereidentified and reviewed in an integrative method. After a criterial analysis, 3 articles were included on this mini review. Results: Two studies found that Garcinia Cambogia in association with Glucomannan had a positive associationrelated to comorbidities as Diabetes Mellitus and its markers (glycemia, triglycerides, cholesterol). However, a case report showed an adverse effect on a high dose Garcinia Cambogia consumption. Conclusion: It is possible that Garcinia Cambogia consumption influences DiabetesMellituscondition, althoughmore studies are necessary for higher efficacy understanding.